Skip to main content
Erschienen in: AIDS and Behavior 7/2011

01.10.2011 | Original Paper

Poverty, Hunger, Education, and Residential Status Impact Survival in HIV

verfasst von: James McMahon, Christine Wanke, Norma Terrin, Sally Skinner, Tamsin Knox

Erschienen in: AIDS and Behavior | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Despite combination antiretroviral therapy (ART), HIV infected people have higher mortality than non-infected. Lower socioeconomic status (SES) predicts higher mortality in many chronic illnesses but data in people with HIV is limited. We evaluated 878 HIV infected individuals followed from 1995 to 2005. Cox proportional hazards for all-cause mortality were estimated for SES measures and other factors. Mixed effects analyses examined how SES impacts factors predicting death. The 200 who died were older, had lower CD4 counts, and higher viral loads (VL). Age, transmission category, education, albumin, CD4 counts, VL, hunger, and poverty predicted death in univariate analyses; age, CD4 counts, albumin, VL, and poverty in the multivariable model. Mixed models showed associations between (1) CD4 counts with education and hunger; (2) albumin with education, homelessness, and poverty; and (3) VL with education and hunger. SES contributes to mortality in HIV infected persons directly and indirectly, and should be a target of health policy in this population.
Literatur
1.
Zurück zum Zitat Huisman M, Kunst AE, Bopp M, Borgan JK, Borrell C, Costa G, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet. 2005;365(9458):493–500.PubMed Huisman M, Kunst AE, Bopp M, Borgan JK, Borrell C, Costa G, et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet. 2005;365(9458):493–500.PubMed
2.
Zurück zum Zitat Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92.PubMedCrossRef Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92.PubMedCrossRef
3.
Zurück zum Zitat Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9.PubMedCrossRef Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9.PubMedCrossRef
4.
Zurück zum Zitat Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33.PubMedCrossRef Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337(11):725–33.PubMedCrossRef
5.
Zurück zum Zitat Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.PubMedCrossRef Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60.PubMedCrossRef
6.
Zurück zum Zitat Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d’Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.PubMedCrossRef Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d’Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22–9.PubMedCrossRef
7.
Zurück zum Zitat Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6.PubMedCrossRef Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med. 1995;333(12):751–6.PubMedCrossRef
8.
Zurück zum Zitat Katz MH, Hsu L, Lingo M, Woelffer G, Schwarcz SK. Impact of socioeconomic status on survival with AIDS. Am J Epidemiol. 1998;148(3):282–91.PubMed Katz MH, Hsu L, Lingo M, Woelffer G, Schwarcz SK. Impact of socioeconomic status on survival with AIDS. Am J Epidemiol. 1998;148(3):282–91.PubMed
9.
Zurück zum Zitat Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy Lazio AIDS Surveillance Collaborative Group. Epidemiol Cambridge Mass. 2000;11(5):496–501. Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy Lazio AIDS Surveillance Collaborative Group. Epidemiol Cambridge Mass. 2000;11(5):496–501.
10.
Zurück zum Zitat Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr. 2002;30(1):111–8. (May 1).PubMed Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr. 2002;30(1):111–8. (May 1).PubMed
11.
Zurück zum Zitat Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994;344(8930):1120–4.PubMedCrossRef Hogg RS, Strathdee SA, Craib KJ, O’Shaughnessy MV, Montaner JS, Schechter MT. Lower socioeconomic status and shorter survival following HIV infection. Lancet. 1994;344(8930):1120–4.PubMedCrossRef
12.
Zurück zum Zitat Schechter MT, Hogg RS, Aylward B, Craib KJ, Le TN, Montaner JS. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol. 1994;47(1):59–67.PubMedCrossRef Schechter MT, Hogg RS, Aylward B, Craib KJ, Le TN, Montaner JS. Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. J Clin Epidemiol. 1994;47(1):59–67.PubMedCrossRef
13.
Zurück zum Zitat McDavid Harrison K, Ling Q, Song R, Hall HI. County-level socioeconomic status and survival after HIV diagnosis, United States. Ann Epidemiol. 2008;18(12):919–27.PubMedCrossRef McDavid Harrison K, Ling Q, Song R, Hall HI. County-level socioeconomic status and survival after HIV diagnosis, United States. Ann Epidemiol. 2008;18(12):919–27.PubMedCrossRef
14.
Zurück zum Zitat McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr. 2003;33(1):96–103. (May 1).PubMedCrossRef McFarland W, Chen S, Hsu L, Schwarcz S, Katz M. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr. 2003;33(1):96–103. (May 1).PubMedCrossRef
15.
Zurück zum Zitat Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 2002;16(15):2065–72. (Oct 18).PubMedCrossRef Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS. 2002;16(15):2065–72. (Oct 18).PubMedCrossRef
16.
Zurück zum Zitat Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5. (Apr 1).PubMedCrossRef Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500–5. (Apr 1).PubMedCrossRef
17.
Zurück zum Zitat Cunningham WE, Hays RD, Duan N, Andersen R, Nakazono TT, Bozzette SA, et al. The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved. 2005;16(4):655–76.PubMed Cunningham WE, Hays RD, Duan N, Andersen R, Nakazono TT, Bozzette SA, et al. The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. J Health Care Poor Underserved. 2005;16(4):655–76.PubMed
18.
Zurück zum Zitat Forrester JE, Spiegelman D, Woods M, Knox TA, Fauntleroy JM, Gorbach SL. Weight and body composition in a cohort of HIV-positive men and women. Public Health Nutr. 2001;4(3):743–7.PubMedCrossRef Forrester JE, Spiegelman D, Woods M, Knox TA, Fauntleroy JM, Gorbach SL. Weight and body composition in a cohort of HIV-positive men and women. Public Health Nutr. 2001;4(3):743–7.PubMedCrossRef
19.
Zurück zum Zitat Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482–9.PubMedCrossRef Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482–9.PubMedCrossRef
22.
Zurück zum Zitat Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544–8.PubMed Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544–8.PubMed
23.
Zurück zum Zitat Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793–801.PubMed Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793–801.PubMed
24.
Zurück zum Zitat Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26(8):775–89.PubMedCrossRef Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26(8):775–89.PubMedCrossRef
25.
Zurück zum Zitat Who is currently living with HIV/AIDS?—Detailed data tables and technical notes: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007. Who is currently living with HIV/AIDS?—Detailed data tables and technical notes: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007.
26.
Zurück zum Zitat Massachusetts HIV/AIDS Data Fact Sheet. Who is most at risk of HIV infection?: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007. Massachusetts HIV/AIDS Data Fact Sheet. Who is most at risk of HIV infection?: Office of HIV/AIDS, Massachussetts Department of Public Health November 2007.
27.
Zurück zum Zitat 2007 Rhode Island HIV/AIDS Epidemiologic Profile With Surrogate Data: Rhode Island Department of Health. Division of Community Family Health and Equity. Office of HIV/AIDS & Viral Hepatitis August 2008. 2007 Rhode Island HIV/AIDS Epidemiologic Profile With Surrogate Data: Rhode Island Department of Health. Division of Community Family Health and Equity. Office of HIV/AIDS & Viral Hepatitis August 2008.
28.
Zurück zum Zitat Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women’s interagency HIV study. AIDS. 1999;13(13):1717–26.PubMedCrossRef Anastos K, Kalish LA, Hessol N, Weiser B, Melnick S, Burns D, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women’s interagency HIV study. AIDS. 1999;13(13):1717–26.PubMedCrossRef
29.
Zurück zum Zitat Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr. 2003;33(1):66–73. (May 1).PubMedCrossRef Feldman JG, Gange SJ, Bacchetti P, Cohen M, Young M, Squires KE, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr. 2003;33(1):66–73. (May 1).PubMedCrossRef
30.
Zurück zum Zitat Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men Multicenter AIDS Cohort Study. J Infect Dis. 2000;181(3):872–80.PubMedCrossRef Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men Multicenter AIDS Cohort Study. J Infect Dis. 2000;181(3):872–80.PubMedCrossRef
34.
Zurück zum Zitat Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS reports. 2007;4(4):181–6.PubMedCrossRef Riley ED, Gandhi M, Hare C, Cohen J, Hwang S. Poverty, unstable housing, and HIV infection among women living in the United States. Current HIV/AIDS reports. 2007;4(4):181–6.PubMedCrossRef
35.
Zurück zum Zitat Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses. 2006;22(1):14–21.PubMedCrossRef Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses. 2006;22(1):14–21.PubMedCrossRef
36.
Zurück zum Zitat Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–54.PubMed Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126(12):946–54.PubMed
37.
Zurück zum Zitat Mason JB. Nutritional Assessment and Management of the Malnourished Patient,Eighth ed. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. W B Saunders Company; 2006. Mason JB. Nutritional Assessment and Management of the Malnourished Patient,Eighth ed. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. W B Saunders Company; 2006.
38.
Zurück zum Zitat Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS care. 2004;16(Suppl 1):S22–42.PubMedCrossRef Klinkenberg WD, Sacks S. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS care. 2004;16(Suppl 1):S22–42.PubMedCrossRef
39.
Zurück zum Zitat Diaz T, Chu SY, Buehler JW, Boyd D, Checko PJ, Conti L, et al. Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med. 1994;10(4):217–22.PubMed Diaz T, Chu SY, Buehler JW, Boyd D, Checko PJ, Conti L, et al. Socioeconomic differences among people with AIDS: results from a Multistate Surveillance Project. Am J Prev Med. 1994;10(4):217–22.PubMed
40.
Zurück zum Zitat Hankins C, Tran T, Hum L, Laberge C, Lapointe N, Lepine D, et al. Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989–1993. Int J Epidemiol. 1998;27(4):691–7.PubMedCrossRef Hankins C, Tran T, Hum L, Laberge C, Lapointe N, Lepine D, et al. Socioeconomic geographical links to human immunodeficiency virus seroprevalence among childbearing women in Montreal, 1989–1993. Int J Epidemiol. 1998;27(4):691–7.PubMedCrossRef
41.
Zurück zum Zitat Zierler S, Krieger N, Tang Y, Coady W, Siegfried E, DeMaria A, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000;90(7):1064–73.PubMedCrossRef Zierler S, Krieger N, Tang Y, Coady W, Siegfried E, DeMaria A, et al. Economic deprivation and AIDS incidence in Massachusetts. Am J Public Health. 2000;90(7):1064–73.PubMedCrossRef
42.
Zurück zum Zitat El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.PubMedCrossRef El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, et al. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283–96.PubMedCrossRef
43.
Zurück zum Zitat Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197(8):1133–44.PubMedCrossRef Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197(8):1133–44.PubMedCrossRef
44.
45.
Zurück zum Zitat Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. Jama. 1998;280(6):547–9.PubMedCrossRef Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. Jama. 1998;280(6):547–9.PubMedCrossRef
46.
Zurück zum Zitat Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94(3):167–73.PubMed Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94(3):167–73.PubMed
47.
Zurück zum Zitat Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18(13):1835–43.PubMedCrossRef Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS. 2004;18(13):1835–43.PubMedCrossRef
48.
Zurück zum Zitat Fox CS, Evans JC, Larson MG, Lloyd-Jones DM, O’Donnell CJ, Sorlie PD, et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol. 2005;95(7):856–9.PubMedCrossRef Fox CS, Evans JC, Larson MG, Lloyd-Jones DM, O’Donnell CJ, Sorlie PD, et al. A comparison of death certificate out-of-hospital coronary heart disease death with physician-adjudicated sudden cardiac death. Am J Cardiol. 2005;95(7):856–9.PubMedCrossRef
Metadaten
Titel
Poverty, Hunger, Education, and Residential Status Impact Survival in HIV
verfasst von
James McMahon
Christine Wanke
Norma Terrin
Sally Skinner
Tamsin Knox
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2011
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9759-z

Weitere Artikel der Ausgabe 7/2011

AIDS and Behavior 7/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.